| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 26.62B | 25.44B | 15.53B | 15.11B | 12.18B |
| Gross Profit | 11.33B | 25.39B | 15.53B | 7.89B | 5.30B |
| EBITDA | 22.69B | 26.08B | 21.88B | 18.55B | 11.51B |
| Net Income | 4.90B | 4.50B | 4.15B | 3.35B | 3.92B |
Balance Sheet | |||||
| Total Assets | 433.66B | 405.85B | 409.69B | 354.72B | 341.84B |
| Cash, Cash Equivalents and Short-Term Investments | 61.85B | 10.36B | 69.44B | 29.76B | 36.83B |
| Total Debt | 365.76B | 343.68B | 342.87B | 298.95B | 294.95B |
| Total Liabilities | 389.66B | 365.59B | 372.41B | 320.43B | 311.73B |
| Stockholders Equity | 43.99B | 40.26B | 37.28B | 34.28B | 30.11B |
Cash Flow | |||||
| Free Cash Flow | -12.06B | -22.54B | 46.67B | 3.06B | -842.62M |
| Operating Cash Flow | 6.34B | 582.68M | 66.83B | 17.00B | 23.71B |
| Investing Cash Flow | -11.52B | -32.53B | -35.32B | -8.79B | -24.12B |
| Financing Cash Flow | 26.15B | -7.16B | -7.49B | -14.47B | -3.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$6.59B | ― | 5.13% | 11.28% | -17.62% | -3.54% | |
65 Neutral | HK$1.39B | 4.31 | 8.51% | 7.43% | -2.69% | -8.21% | |
64 Neutral | HK$19.47B | 1.89 | 12.27% | 5.84% | -6.19% | 11.78% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | HK$262.09M | 6.53 | 1.09% | ― | 8.77% | -76.88% | |
54 Neutral | HK$34.44B | 8.52 | 7.50% | 6.69% | -5.86% | -4.69% | |
42 Neutral | HK$178.85M | -1.47 | -29.10% | ― | -5.72% | -6.26% |